Mediera Corporation (TPEX:5398)
Taiwan · Delayed Price · Currency is TWD 20.00
0.00 (0.00%)
May 8, 2026, 1:30 PM CST
Mediera Market Cap
Mediera has a market cap or net worth of 989.3 million as of May 8, 2026. Its market cap has increased by 25.39% in one year.
Market Cap
989.30M
Enterprise Value
890.29M
Revenue
229.85M
Ranking
n/a
PE Ratio
57.14
Stock Price
20.00
Market Cap Chart
Since November 3, 2004, Mediera's market cap has increased from 257.38M to 989.30M, an increase of 284.37%. That is a compound annual growth rate of 6.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 989.30M | -23.08% |
| Dec 31, 2025 | 1.29B | 33.67% |
| Dec 31, 2024 | 962.10M | 27.54% |
| Dec 29, 2023 | 754.35M | -7.01% |
| Dec 30, 2022 | 811.23M | -19.01% |
| Dec 30, 2021 | 1.00B | 4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 1.97B |
| Tien Liang BioTech | 1.82B |
| GeneFerm Biotechnology | 1.56B |
| InnoPharmax | 1.54B |
| Winston Medical Supply | 1.26B |
| DV Biomed | 1.17B |
| Excelsior Biopharma | 1.14B |
| Prince Pharmaceutical | 1.13B |